Antithrombotic therapy at the end-of-life—continue or stop?
Antithrombotic therapy at the end-of-life—continue or stop? Gerard Gurumurthy 1,2;…
Ler MaisAntiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics
Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic…
Ler Mais